期刊文献+

外源性FHIT基因表达对胃癌细胞株MGC-803凋亡作用的影响 被引量:2

Effect of fragile histidine triad gene on apoptosis of MGC-803 gastric cancer cells
下载PDF
导出
摘要 目的 :探讨外源性 FHIT基因的表达对胃癌细胞株凋亡作用的影响。方法 :将载有人外源性 FHIT基因的真核表达质粒 p Rc CMV- FHIT用脂质体介导转入胃癌细胞株 MGC- 80 3,用流式细胞仪、普通光镜、透射电镜观察 FHIT基因的表达对 MGC- 80 3细胞凋亡的影响。结果 :转染 FHIT基因的 MGC- 80 3细胞的凋亡水平 (32 % )与空质粒转染组 (12 .15 % )相比明显增高 ,且存在显著性差异 (P<0 .0 1) ,同时细胞的生长周期出现了明显的 G0 /G1期阻滞 (6 4.375 % vs 4 9.5 % )。结论 :外源性 FHIT基因能诱导胃癌细胞株 MGC- 80 3凋亡 ,细胞生长周期阻滞。 Objective: To investigate the effect of fragile hisdidine triad (FHIT) gene on the apoptosis of gastric cancer cells. Methods: FHIT gene was transfected into gastric cancer cell line MGC-803 by liposome. Western blot and immunohistochemical assay were employed to detect the expression of FHIT. Apoptosis and cell cycle were analyzed by flow cytometry (FCM). Morphological changes were observed by light and electron microscope. Results: Stable expression of FHIT protein in transfected MGC-803 cells was obtained. The rates of G0/G1 phase and apoptosis cells were significantly higher in FHIT-transfected MGC-803 cells than those in control cells (64.4% vs 49.5% and 32.0% vs 12.2%, respectively). Conclusion: The results indicate that FHIT gene might be involved in the apoptosis of gastric cancer cells.
机构地区 浙江大学医学院
出处 《浙江大学学报(医学版)》 CAS CSCD 2004年第2期133-137,共5页 Journal of Zhejiang University(Medical Sciences)
关键词 胃肿瘤/遗传学 FHIT基因 胃癌 基因转染 凋亡 Stomach neoplasms/genet FHIT gene Gastric cancer Gene transfection Apoptosis
  • 相关文献

参考文献16

  • 1[1]OHTA M, INOUE H, COTTICELLI M G, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3;8) breakpoint, is abnormal in digestive tract cancers [J]. Cell, 1996,84:587-597.
  • 2[2]LEE S H, KIM W H, KIM H K, et al. Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas [J]. Biochem Biophys Res Commun, 2001,284(3):850-855.
  • 3[3]CASELLI M, MARCHISIO M, GAUDIO M, et al. Fhit protein expression in human gastric cancer and related precancerous lesions [J]. Oncol Rep, 2001,8(6):1233-1237.
  • 4[4]SIPRASHVILI Z, SOZZI G, BARNES L D, et al. Replacement of Fhit in cancer cells suppresses tumorigenicity [J]. Proc Natl Acad Sci USA, 1997,94(25):13771-13776.
  • 5[5]SOZZI G, PASTORINO U, MOIRAGHI L, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions [J]. Cancer Res, 1998,58:5032-5037.
  • 6[6]BAFFA R, VERONESE M L, SANTORO R, et al. Loss of FHIT expression in gastric carcinoma [J]. Cancer Res, 1998,58(20):4708-4714.
  • 7[7]BIRRER M J, HENDRICKS D, FARLEY J, et al. Abnormal Fhit expression in malignant and premalignant lesions of the cervix [J]. Cancer Res, 1999,59:5270-5274.
  • 8[8]MICHAEL D, BEER D G, WILKE C W, et al. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas [J]. Oncogene,1997,15(14):1653-1659.
  • 9[9]CAMPIGLIO M, PEKARSKY Y, MENARD S, et al. FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease [J]. Cancer Res, 1999,59:3866-3869.
  • 10[10]SORIO C,BARON A,ORLANDINI S,et al.The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers [J]. Cancer Res, 1999,59:1308-1314.

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部